Based on the analysis of these datasets, we detected a significant decrease (p < 0.0001) in the mRNA level of PLA2R1 in Grade II and III in comparison to Grade I breast cancer (Figure 1A). This evidence concerns the gene PLA2R1 and breast cancer.